Violetta V. Leshchenko

Discovery of a first-in-class EZH2 selective degrader

Anqi Ma, Kwang‐Su Park, Jieli Wei et al. · Nature Chemical Biology · 2019 · 227 citations · Full text

Life Sciences, Genetics, Molecular Biology +4

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

Matko Kalac, Luigi Scotto, Enrica Marchi et al. · Blood · 2011 · 155 citations · Full text

Medicine, Molecular Biology, Oncology +12

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma

Violetta V. Leshchenko, Pei-Yu Kuo, Rita Shaknovich et al. · Blood · 2010 · 134 citations · Full text

Medicine, Genetics, Oncology +14

Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Deepak Perumal, Naoko Imai, Alessandro Laganà et al. · Clinical Cancer Research · 2019 · 86 citations · Full text

Life Sciences, Immunology, Oncology +17

Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications

Sherry Bhalla, David T. Melnekoff, Adolfo Aleman et al. · Science Advances · 2021 · 74 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11